Acuren Corporation has announced a merger with NV5, with the transaction expected to close in the second half of 2025. Under the terms of the agreement, NV5 stockholders will receive $23.00 per share, comprising $10.00 in cash and $13.00 in stock, representing a 32% premium to NV5's 30-day volume weighted average price as of May 14, 2025. This merger is seen as a strategic move to expand and complement the business lines of both companies, offering significant value to their stockholders. The agreement includes a 60-day "go-shop" period for NV5 and is subject to approval by stockholders and regulatory bodies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.